v3.26.1
Fair Value Disclosures - Schedule of Estimate to Measure Contingent Consideration Unobservable Level 3 In-process R&D (Details) - Multi-Period Excess Earnings Method
Dec. 31, 2025
KIO-104 | Discount Rate  
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]  
In-process R&D 0.395
KIO-104 | Minimum | Probability of success for next development phase  
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]  
In-process R&D 0.17
KIO-104 | Maximum | Probability of success for next development phase  
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]  
In-process R&D 0.36
KIO-301 | Discount Rate  
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]  
In-process R&D 0.395
KIO-301 | Minimum | Probability of success for next development phase  
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]  
In-process R&D 0.23
KIO-301 | Maximum | Probability of success for next development phase  
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]  
In-process R&D 0.43